Verónica Jiménez

Universitat Autònoma de Barcelona — Spain

Medicine · Health Sciences

23h-index2.1kcitations51works3.12yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Pancreatic function and diabetes(17), Virus-based gene therapy research(12), Diabetes and associated disorders(9), Adipose Tissue and Metabolism(8), Cancer, Hypoxia, and Metabolism(7)

Publications51 total

Deciphering the Clinical Heterogeneity and Molecular Underpinnings of Hypertrophic Cardiomyopathy: A Contemporary Synthesis of Genetic, Diagnostic, and Therapeutic Paradigms
International Journal of Medical Science and Clinical Research Studies·2025Open Access
Nuclear hormone-sensitive lipase regulates adipose tissue mass and adipocyte metabolism
Repository for Publications and Research Data (ETH Zurich)·2025Open Access
Abstract 4368833: A RETRO-ENANTIOMER OF ANGIOTENSIN-(1-9) PREVENTS THE DEVELOPMENT OF HEART FAILURE WITH PRESERVED EJECTION FRACTION.
Circulation·2025
A myotropic AAV vector combined with skeletal muscle cis-regulatory elements improve glycogen clearance in mouse models of Pompe disease
Molecular Therapy — Methods & Clinical Development·2025· 5 citedOpen Access
Rat models of musculoskeletal lysosomal storage disorders and their role in pre-clinical evaluation of gene therapy approaches
Mammalian Genome·2025· 1 citedOpen Access
Reversion of metabolic dysfunction-associated steatohepatitis by skeletal muscle-directed FGF21 gene therapy
Molecular Therapy·2024· 13 citedOpen Access
Acute Myocardial Infarction in the Context of Diabetic Ketoacidosis: Pathophysiological Interactions, Clinical Manifestations, and Therapeutic Considerations
International Journal of Medical Science and Clinical Research Studies·2024Open Access
880-P: Gene Therapy for MODY3 Moving from Mice to Large Animals
Diabetes·2024
898-P: AAV-FGF21 Gene Therapy Extends Healthspan in Old Mice
Diabetes·2024· 1 cited
883-P: Brain-Directed AAV-FGF21 Gene Therapy Reverses Type 2 Diabetes, Obesity, and Cognitive Decline
Diabetes·2024
Treatment of infantile-onset Pompe disease in a rat model with muscle-directed AAV gene therapy
Molecular Metabolism·2024· 16 citedOpen Access
Gene Therapy for Diabetes
2024· 1 cited
Arginine reprograms metabolism in liver cancer via RBM39
Cell·2023· 240 citedOpen Access
P16 An investigational AAV8 gene therapy coding for a novel microdystrophin as a treatment for Duchenne muscular dystrophy
Neuromuscular Disorders·2023
838-P: Reversion of Nonalcoholic Steatohepatitis by Skeletal-Muscle Directed FGF21 Gene Therapy
Diabetes·2023
826-P: Treatment of MODY3 Disease by AAV-Hnf1a-Mediated Gene Therapy
Diabetes·2023· 1 cited
855-P: Evolution of KT-A112, an AAV-Mediated Gene Therapy for the Treatment of Type 1 Diabetes
Diabetes·2023
Integrated gene expression profiles reveal a transcriptomic network underlying the thermogenic response in adipose tissue
Scientific Reports·2023· 10 citedOpen Access
Interaction of a viral insulin-like peptide with the IGF-1 receptor produces a natural antagonist
Nature Communications·2022· 24 citedOpen Access
AAV-mediated BMP7 gene therapy counteracts insulin resistance and obesity
Molecular Therapy — Methods & Clinical Development·2022· 26 citedOpen Access
page 1 of 3Next →

Frequent Co-authors

Fátima Bosch(41), Miquel García(15), Estefanía Casana(13), Sergio Muñoz(13), Alba Casellas(13), Claudia Jambrina(12), Victor Sacristan(12), Tura Ferré(11), Sylvie Franckhauser(11), Eduard Ayuso(11), Cristina Mallol(10), Xavier León(10), Jordi Rodó(8), Ivet Elias(8), Jesús Ruberte(8), Albert Ribera(7), Virginia Haurigot(7), Maria Luisa Jaén(7), Ignasi Grass(6), Judith Agudo(6)